Le Lézard
Classified in: Health, Covid-19 virus
Subject: FDA

GetMyDNA Receives FDA EUA for COVID-19 Test Home Collection Kit for Direct-to-Consumer Purchase


COVINGTON, Ky., March 10, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued emergency use authorization (EUA) to launch the GetMyDNA COVID-19 Test Home Collection Kit DTC, which is now available for broad use for both symptomatic and asymptomatic individuals with no prescription required. This news means the COVID-19 Test Home Collection Test Kit DTC is available without a doctor's prescription and can be given directly to individuals who are not experiencing symptoms from COVID-19. Negative results will be delivered directly to the individual via email, while positive results will be delivered through a healthcare provider to the individual.

"Since March 16, 2020, when Gravity Diagnostics starting processing COVID-19 samples, we always focused on how best to utilize our capacity to help those most in need of rapid gold-standard PCR testing. We purposely delayed applying for an FDA EUA for a home testing solution early on, but as things developed last year, we saw another population emerge that needed access to low-priced home testing with gold-standard PCR results. We then expedited our submission in order to attempt to serve those individuals. Today is a huge milestone for GetMyDNA. We are very thankful for the FDA and the amazing work they have done the last twelve months navigating a very complex set of challenges," said Tony Remington, co-founder, and chief executive officer of Gravity Diagnostics and GetMyDNA.

How It Works 
The GetMyDNA COVID-19 Test Home Collection Kit DTC is an FDA-authorized mail-in home collection test kit for COVID-19 and is available for individuals 18 years and older in all 50 U.S. states. This test provides the gold-standard anterior nasal swab PCR (Polymerase Chain Reaction) test that checks for genetic material produced by the virus and can determine whether an asymptomatic or symptomatic individual is infected with COVID-19. A PCR test is a highly reliable, high-complexity laboratory test. The test will be available for order online at getmydna.com at $99 a kit with an introductory offer of $20 off with code LAUNCH20, making the test only $79 with free overnight shipping both ways.

"After founding Gravity Diagnostics in 2016, a CLIA-certified, CAP-accredited laboratory licensed in all 50 states, we founded our home-testing diagnostics company, GetMyDNA, in 2018. Our intention was always that home-testing solutions and telemedicine would have an important place in the future of healthcare and empower individuals to take more control over their health and wellness. We are thrilled to launch our direct-to-consumer COVID-19 home solution to serve more populations in need of accurate, timely testing as we all navigate back to work, back to school, and back to life. This is just the beginning of what we foresee GetMyDNA being able to do for consumers in all 50 states," said Julie Brazil, co-founder, and chief operating officer of Gravity Diagnostics and GetMyDNA. 

An essential aspect of at-home testing is the ability to have accurate and timely results. GetMyDNA provides overnight shipping both ways while offering a competitive price. GetMyDNA is powered by Gravity Diagnostics, a CLIA-certified, CAP-accredited laboratory that provides same-day results for 99% of samples received. 

About GetMyDNA  
GetMyDNA provides affordable and reliable diagnostic home-testing solutions backed by telemedicine across the U.S. GetMyDNA is currently focused on providing gold-standard PCR COVID-19 testing and results through their FDA-authorized COVID-19 Test Home Collection Kit DTC. In the future, the company will be adding a suite of additional home testing solutions, including a Pharmacogenomics (PGx) kit, which inspired the name GetMyDNA. Learn more at getmydna.com.

Media Contact: [email protected] 

About Gravity Diagnostics 
Gravity Diagnostics is a full-service state-of-the-art CLIA-certified and CAP-accredited laboratory licensed in all 50 states providing innovative laboratory testing in the areas of COVID-19, Upper Respiratory, Toxicology, Pharmacogenomics, and Sexually Transmitted Infections. They are an advocate for physicians, patients, and their communities, supporting them with unsurpassed integrity, regulatory compliance, and clinical expertise. Gravity currently services over 750 customers from small private practices to universities to Fortune 500 companies. Learn more at gravitydiagnostics.com.

 Media Contact: [email protected]

SOURCE GetMyDNA


These press releases may also interest you

at 06:00
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...



News published on and distributed by: